BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 31116395)

  • 1. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
    Urban P; Mehran R; Colleran R; Angiolillo DJ; Byrne RA; Capodanno D; Cuisset T; Cutlip D; Eerdmans P; Eikelboom J; Farb A; Gibson CM; Gregson J; Haude M; James SK; Kim HS; Kimura T; Konishi A; Laschinger J; Leon MB; Magee PFA; Mitsutake Y; Mylotte D; Pocock S; Price MJ; Rao SV; Spitzer E; Stockbridge N; Valgimigli M; Varenne O; Windhoevel U; Yeh RW; Krucoff MW; Morice MC
    Eur Heart J; 2019 Aug; 40(31):2632-2653. PubMed ID: 31116395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.
    Urban P; Mehran R; Colleran R; Angiolillo DJ; Byrne RA; Capodanno D; Cuisset T; Cutlip D; Eerdmans P; Eikelboom J; Farb A; Gibson CM; Gregson J; Haude M; James SK; Kim HS; Kimura T; Konishi A; Laschinger J; Leon MB; Magee PFA; Mitsutake Y; Mylotte D; Pocock S; Price MJ; Rao SV; Spitzer E; Stockbridge N; Valgimigli M; Varenne O; Windhoevel U; Yeh RW; Krucoff MW; Morice MC
    Circulation; 2019 Jul; 140(3):240-261. PubMed ID: 31116032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval Studies.
    Chandiramani R; Cao D; Claessen BE; Sorrentino S; Guedeney P; Blum M; Goel R; Roumeliotis A; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Bangalore S; Bhatt DL; Angiolillo DJ; Ruster K; Wang J; Saito S; Neumann FJ; Hermiller J; Valgimigli M; Mehran R
    J Am Heart Assoc; 2020 Apr; 9(7):e014611. PubMed ID: 32223396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.
    Baber U; Mehran R; Giustino G; Cohen DJ; Henry TD; Sartori S; Ariti C; Litherland C; Dangas G; Gibson CM; Krucoff MW; Moliterno DJ; Kirtane AJ; Stone GW; Colombo A; Chieffo A; Kini AS; Witzenbichler B; Weisz G; Steg PG; Pocock S
    J Am Coll Cardiol; 2016 May; 67(19):2224-2234. PubMed ID: 27079334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison and Validation of Long-Term Bleeding Events for Academic Bleeding Risk (ARC-HBR) Criteria and Contemporary Risk Scores for Percutaneous Coronary Intervention With a Second-Generation Drug Eluting Stent.
    Okabe K; Miura K; Shima Y; Ikuta A; Taguchi Y; Takahashi K; Osakada K; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    Circ J; 2022 Aug; 86(9):1379-1387. PubMed ID: 35400715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document.
    Garot P; Morice MC; Angiolillo DJ; Cabau JR; Park DW; Van Mieghem NM; Collet JP; Leon MB; Sengottuvelu G; Neylon A; Ten Berg JM; Mylotte D; Tchétché D; Krucoff MW; Reardon MJ; Piazza N; Mack MJ; Généreux P; Makkar R; Hayashida K; Ohno Y; Mochizuki S; Shirai Y; Matsumara R; Jin Y; Webb JG; Cutlip DE; Chen M; Spitzer E; Mehran R; Capodanno D
    EuroIntervention; 2024 May; 20(9):536-550. PubMed ID: 38726720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.
    Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T
    Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention.
    Abu-Assi E; Raposeiras-Roubín S; Cespón Fernández M; Caneiro Queija B; Melendo Viu M; Íñiguez Romo A
    Rev Esp Cardiol (Engl Ed); 2022 May; 75(5):375-383. PubMed ID: 33865751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk.
    Baber U; Leisman DE; Cohen DJ; Gibson CM; Henry TD; Dangas G; Moliterno D; Kini A; Krucoff M; Colombo A; Chieffo A; Sartori S; Witzenbichler B; Steg PG; Pocock SJ; Mehran R
    Circ Cardiovasc Qual Outcomes; 2019 Jan; 12(1):e004945. PubMed ID: 30606052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing percutaneous coronary interventions.
    Neupane S; Khawaja O; Edla S; Singh H; Othman H; Bossone E; Yamasaki H; Rosman HS; Eggebrecht H; Mehta RH
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):98-104. PubMed ID: 30585391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).
    Baber U; Li SX; Pinnelas R; Pocock SJ; Krucoff MW; Ariti C; Gibson CM; Steg PG; Weisz G; Witzenbichler B; Henry TD; Kini AS; Stuckey T; Cohen DJ; Iakovou I; Dangas G; Aquino MB; Sartori S; Chieffo A; Moliterno DJ; Colombo A; Mehran R
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e006144. PubMed ID: 29870385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of the Academic Research Consortium for High Bleeding Risk Criteria and Prognostic Value of a Simplified Definition.
    Miura K; Shimada T; Ohya M; Murai R; Amano H; Kubo S; Tada T; Tanaka H; Fuku Y; Goto T; Kadota K
    Circ J; 2020 Aug; 84(9):1560-1567. PubMed ID: 32669530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Antithrombotic Strategies and Coronary Stent Technologies for Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention.
    Sorrentino S; Salerno N; Leo I; Polimeni A; Sabatino J; Spaccarotella CAM; Mongiardo A; De Rosa S; Indolfi C
    Curr Vasc Pharmacol; 2022; 20(1):37-45. PubMed ID: 34370641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.
    Cao D; Mehran R; Dangas G; Baber U; Sartori S; Chandiramani R; Stefanini GG; Angiolillo DJ; Capodanno D; Urban P; Morice MC; Krucoff M; Goel R; Roumeliotis A; Sweeny J; Sharma SK; Kini A
    J Am Coll Cardiol; 2020 Jun; 75(21):2711-2722. PubMed ID: 32466887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT.
    Zocca P; Kok MM; van der Heijden LC; van Houwelingen KG; Hartmann M; de Man FHAF; Stoel MG; Louwerenburg JHW; Knottnerus IL; Linssen GCM; Doggen CJM; von Birgelen C
    Int J Cardiol; 2018 Oct; 268():11-17. PubMed ID: 29801763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome.
    Shimono H; Tokushige A; Kanda D; Ohno A; Hayashi M; Fukuyado M; Akao M; Kawasoe M; Arikawa R; Otsuji H; Chaen H; Okui H; Oketani N; Ohishi M
    J Cardiol; 2023 Jun; 81(6):553-563. PubMed ID: 36682715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria.
    Spirito A; Gragnano F; Corpataux N; Vaisnora L; Galea R; Svab S; Gargiulo G; Siontis GCM; Praz F; Lanz J; Billinger M; Hunziker L; Stortecky S; Pilgrim T; Capodanno D; Urban P; Pocock S; Mehran R; Heg D; Windecker S; Räber L; Valgimigli M
    J Am Heart Assoc; 2021 Jun; 10(12):e021965. PubMed ID: 34098740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial.
    Ariotti S; Adamo M; Costa F; Patialiakas A; Briguori C; Thury A; Colangelo S; Campo G; Tebaldi M; Ungi I; Tondi S; Roffi M; Menozzi A; de Cesare N; Garbo R; Meliga E; Testa L; Gabriel HM; Ferlini M; Vranckx P; Valgimigli M;
    JACC Cardiovasc Interv; 2016 Mar; 9(5):426-36. PubMed ID: 26965932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications and characteristics of high bleeding risk in East Asian patients undergoing percutaneous coronary intervention: Start with what is right rather than what is acceptable.
    Nakamura M; Iijima R
    J Cardiol; 2021 Aug; 78(2):91-98. PubMed ID: 33358236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ischemic risk factors on long-term outcomes in patients with and without high bleeding risk.
    Shima Y; Miura K; Shimada T; Ohya M; Murai R; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    Int J Cardiol; 2021 Mar; 326():12-18. PubMed ID: 33152414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.